The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
Abstract
Unlabelled Application of the WHO fracture prediction algorithm in conjunction with an updated US economic analysis indicates that osteoporosis treatment is cost-effective in patients with fragility fractures or osteoporosis, in older individuals at average risk and in younger persons with additional clinical risk factors for fracture, supporting existing practice recommendations. Introduction The new WHO fracture prediction algorithm was combined with an updated economic analysis to evaluate existing NOF guidance for osteoporosis prevention and treatment. Methods The WHO fracture prediction algorithm was calibrated to the US population using national age-, sex- and race-specific death rates and age- and sex-specific hip fracture incidence rates from the largely white population of Olmsted County, MN. Fracture incidence for other races was estimated by ratios to white women and men. The WHO algorithm estimated the probability (%) of a hip fracture (or a major osteoporotic fracture) over 10 years, given specific age, gender, race and clinical profiles. The updated economic model suggested that osteoporosis treatment was cost-effective when the 10-year probability of hip fracture reached 3%. Results It is cost-effective to treat patients with a fragility fracture and those with osteoporosis by WHO criteria, as well as older individuals at average risk and osteopenic patients with additional risk factors. However, the estimated 10-year fracture probability was lower in men and n…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter analyses generally confirm the previous NOF conclusion that it is cost-effective to treat individuals with a prior hip or vertebral fracture and those with a DXA femoral neck T-score ≤−2.5.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [13]
In the citing paper
“The latter analyses generally confirm the previous NOF conclusion that it is cost-effective to treat individuals with a prior hip or vertebral fracture and those with a DXA femoral neck T-score ≤−2.5.”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [13]
In the citing paper
“Therapeutic intervention thresholds are based on NOF’s economic analysis that takes into consideration the cost-effectiveness of treatments and competition for resources in the USA [12, 13].”
From Clinician’s Guide to Prevention and Treatment of Osteoporosis (2014) · cites this paper as [13]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 2×
“Questions have been raised about the utility of estrogen therapy [6, 7], the mainstay of earlier treatment recommendations for postmenopausal women [5], and new drugs have been introduced [8].”
BackgroundPrevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190 · cited 1×
“Since BMI is strongly correlated with femoral neck BMD, and is less useful for fracture risk prediction when hip BMD is available [33], analyses were adjusted to the upper limit of “healthy” weight, a BMI of 24.9 [ 34 ].”
Influential(2004) · JAMA · doi:10.1001/jama.291.14.1701 · Cited by 4,534 · cited 2×
“Questions have been raised about the utility of estrogen therapy [6, 7], the mainstay of earlier treatment recommendations for postmenopausal women [5], and new drugs have been introduced [8].”
BackgroundIncidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
Burge, R., Dawson-Hughes, B., Solomon, D. H., Wong, J. B., King, A., & Tosteson, A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061113 · Cited by 4,026 · cited 5×
“Thresholds for evaluating the cost-effectiveness of treatment have been revised [11], and of course, costs have also increased [10].”
BackgroundMethodInfluentialSelf-citationProfessor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Self-citationEpidemiology and outcomes of osteoporotic fractures
Cummings, S. R., & Melton, L. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08657-9 · Cited by 3,821 · cited 2×
“This is partly due to the fact that average hip fracture risk in these groups is substantially less than that in white women [32].”
BackgroundResultSelf-citationFRAX™ and the assessment of fracture probability in men and women from the UK
Kanis, J. A., Johnell, O., Oden, A., Johansson, H., & McCloskey, E. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0543-5 · Cited by 2,467 · cited 4×
“As described elsewhere [12], the risk factors include age, femoral neck BMD (T-score or Z-score compared to norms from the National Health and Nutrition Examination Survey [18]) and body mass index (BMI) as continuous variables, along with a personal history of prior fragility fracture, rheumatoid arthritis, other put…”
BackgroundMethodInfluentialCummings, S. R. (1998) · JAMA · doi:10.1001/jama.280.24.2077 · Cited by 2,277 · cited 1×
“the costs and complications of therapy, even presuming that treatment would be efficacious in osteopenic women generally [46].”
BackgroundDiagnosis of osteoporosis and assessment of fracture risk
Kanis, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08761-5 · Cited by 2,260 · cited 1×
“Thus, the 10-year fracture probability in an average-risk 50-year-old white woman is quite low [60], suggesting that treatment of such patients will not be costeffective [13, 61].”
BackgroundBlack, D. M., & Rosen, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1513724 · Cited by 1,712
Research works printed but not linked: 1
- U.S.D.H.H.S. (2004) Chapter 4. The Frequency of Bone Disease. Bone Health and Osteoporosis: A Report of the Surgeon General. U.S. Department of Health and Human Services, Rockville, MD, pp 69–87
Cited by
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Self-citationEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
The clinician's guide to prevention and treatment of osteoporosis
LeBoff, M. S., Greenspan, S. L., Insogna, K. L., Lewiecki, E. M., Saag, K. G., Singer, A. J., & Siris, E. S. (2022) · Osteoporosis International · doi:10.1007/s00198-021-05900-y · Cited by 1,487
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
“Decision-Making on Pharmacologic Therapy Therapeutic intervention thresholds vary from country to country based on the cost of treatments, the approach taken to setting the intervention threshold, and available therapeutic modalities and resources (206,209).”
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Metadata
- Authors
- Dawson-Hughes, B., Tosteson, A. N. A., Melton, L. J., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L.
- Affiliations
- Dartmouth Institute for Health Policy and Clinical Practice (US)
- Mayo Clinic (US)
- Medical College of Wisconsin (US)
- University of Chicago (US)
- Helen Hayes Hospital (US)
- Venue
- Osteoporosis International
- Published
- 2008-02-22
- Volume
- 19
- Issue
- 4
- Pages
- 449-458
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2059857909
- Cited by
- 427
- References
- 63
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 15 · 2021: 9 · 2020: 22 · 2019: 12 · 2018: 10 · 2017: 15 · 2016: 18 · 2015: 23 · 2014: 22 · 2013: 31 · 2012: 32
- FWCI
- 60.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG012262)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Surgery › Hip and Femur Fractures
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- osteoporosis, fracture risk assessment, cost-effectiveness, osteoporosis treatment, hip fracture, fragility fractures, osteoporosis prevention, shared decision-making, Olmsted County, Minnesota
- MeSH terms
- Aged, Aged, 80 and over, Algorithms, Cost-Benefit Analysis, Female, Hip Fractures, Humans, Male, Middle Aged, Osteoporosis, Probability, United States, Bone Density, Spinal Fractures, Practice Guidelines as Topic, Age Distribution, Risk Assessment, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. https://app.cochat.ai/papers/10.1007/s00198-008-0559-5
- The paper
- Dawson-Hughes, B., Tosteson, A. N. A., Melton, L. J., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008). Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporosis International. https://doi.org/10.1007/s00198-008-0559-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.